Skip to main content


Biopharmaceutical Development Program (BDP)

The Biopharmaceutical Development Program (BDP) provides resources for development of investigational biological agents. The BDP supports feasibility through development and Phase I/II cGMP manufactur… [learn more]

NCI Project Officer: Anthony Welch, PhD
Phone: 301-846-5691

Molecular Targets Program

Molecular Targets Program support measurement of molecular targets in the NCI panel 60 human tumor cell lines. Targets include gene mutations, mRNA levels, protein levels and enzyme activities.

Facility Head: Susan Holbeck, PhD
Phone: 301-435-9178
Go to top